Publications by authors named "Christiane Vank"

Claim this Profile
R
Risk factors for enterococcal urinary tract infections: a multinational, retrospective cohort study.
Adi Turjeman, Tanya Babich, Miquel Pujol, Jordi Carratalà, Evelyn Shaw, Christiane Vank

Eur J Clin Microbiol Infect Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for hospital readmission following complicated urinary tract infection.
Tanya Babich, Noa Eliakim-Raz, Adi Turjeman, Miquel Pujol, Jordi Carratalà, Christiane Vank

Sci Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study.
Aina Gomila, Jordi Carratalà, Noa Eliakim-Raz, Evelyn Shaw, Cristian Tebé, Christiane Vank

Antimicrob Resist Infect Control· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections.
Aina Gomila, Evelyn Shaw, Jordi Carratalà, Leonard Leibovici, Cristian Tebé, Christiane Vank

Antimicrob Resist Infect Control· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Treatment Failure and Mortality Among Hospitalized Patients With Complicated Urinary Tract Infection: A Multicenter Retrospective Cohort Study (RESCUING Study Group).
Noa Eliakim-Raz, Tanya Babitch, Evelyn Shaw, Ibironke Addy, Irith Wiegand, Christiane Vank

Clin Infect Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study.
Laura Vallejo-Torres, Miquel Pujol, Evelyn Shaw, Irith Wiegand, Joan Miquel Vigo, Christiane Vank

BMJ Open· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING).
Evelyn Shaw, Ibironke Addy, Margaret Stoddart, Christiane Vank, Sally Grier

BMJ Open· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase I study of the liposomal RNA interference therapeutic Atu027 in patients with advanced solid tumors.
Beate Schultheis, Dirk Strumberg, Ansgar Santel, Christiane Vank, Frank Gebhardt

J Clin Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors.
Dirk Strumberg, Beate Schultheis, Ulrich Traugott, Christiane Vank, Ansgar Santel

Int J Clin Pharmacol Ther· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atu027 prevents pulmonary metastasis in experimental and spontaneous mouse metastasis models.
Ansgar Santel, Manuela Aleku, Nadine Röder, Kristin Möpert, Birgit Durieux, Christiane Vank

Clin Cancer Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis